BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-07 16:37 |
DGAP-DD: BRAIN Biotech AG english
|
English | HTML • 8.0 KB | ||
| 2022-04-04 10:40 |
BRAIN Biotech AG: Successful Genome Editing in Mammalian Cells with BRAIN-Metag…
|
English | HTML • 11.9 KB | ||
| 2022-04-04 10:31 |
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BR…
|
English | HTML • 7.3 KB | ||
| 2022-03-09 16:00 |
BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year…
|
English | HTML • 10.8 KB | ||
| 2022-02-25 00:00 |
Q1 statement / Q1 financial report 2021/2022
|
English | PDF • 118.4 KB | ||
| 2022-02-23 07:30 |
BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting
|
English | HTML • 18.1 KB | ||
| 2022-02-22 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.10.2020 bis zum 30.09.2021
|
German | ZIP • 643.5 KB | ||
| 2022-02-22 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.10.2020 bis zum 30.09.2021
|
German | ZIP • 1.4 MB | ||
| 2022-02-08 08:15 |
BRAIN Biotech and Formo: Strategic partnership of European biotech experts for …
|
English | HTML • 12.4 KB | ||
| 2022-02-01 17:45 |
BRAIN Group significantly expands its food enzyme business with the acquisition…
|
English | HTML • 13.8 KB | ||
| 2022-02-01 17:36 |
BRAIN Biotech AG: BRAIN Group expands its food enzyme business with the acquisi…
|
English | HTML • 7.0 KB | ||
| 2022-01-28 15:05 |
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.03.…
|
German | HTML • 103.1 KB | ||
| 2022-01-18 00:00 |
Annual financial report 2020/2021
|
English | PDF • 4.2 MB | ||
| 2022-01-17 07:30 |
BRAIN Biotech AG publishes Annual Report for FY 2020/21
|
English | HTML • 13.6 KB | ||
| 2022-01-11 18:50 |
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
|
English | HTML • 10.4 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
